Analyze Diet
Veterinary ophthalmology2017; 20(6); 539-546; doi: 10.1111/vop.12465

Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?

Abstract: This study aimed to assess the biofilm-forming ability of Candida spp. from the ocular conjunctiva of horses and to investigate the antifungal susceptibility of these biofilms. Methods: Initially, the biofilm-forming ability of 15 strains was assessed by crystal violet staining, which reveals the fungal biomass adhered to the polystyrene plates, and scanning electron microscopy. Then, the minimum inhibitory concentrations (MICs) of amphotericin B, fluconazole, itraconazole, and caspofungin were initially determined against strains in planktonic form. Afterward, antifungal susceptibility of mature biofilms was evaluated by exposing them to 10 × MIC and 50 × MIC of the tested drugs, followed by the assessment of their metabolic activity, using the oxidoreduction indicator XTT. Results were analyzed through ANOVA and Tukey's post-test, and P-values below 5% led to significant conclusions. Results: Eight strains produced biofilms and were classified as strong (1/15), moderate (3/15) and weak (4/15) producers, according to the amount of crystal violet retained by the adhered fungal biomass. Biofilm metabolic activity of one C. tropicalis did not decrease after exposure to the tested antifungals, while biofilm metabolic activity of five strains was reduced by amphotericin B, but not the other drugs. One C. parapsilosis sensu stricto and one C. glabrata showed significant reduction in biofilm metabolic activity after exposure to fluconazole, itraconazole, and caspofungin, but not amphotericin B. Conclusions: The results demonstrate that Candida from the ocular conjunctiva of horses can pose as a risk to animal health as they are capable of forming biofilms, which are commonly involved in fungal keratitis.
Publication Date: 2017-04-18 PubMed ID: 28417524DOI: 10.1111/vop.12465Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about a study on the ability of Candida species to form biofilms on the ocular surface of horses, and the role of this biofilm formation in complicating the treatment of fungal eye infections in horses.

Objectives and Methods of the Research

  • The study aimed at assessing the biofilm-forming capacity of 15 strains of Candida species isolated from horses’ ocular conjunctiva.
  • The biofilm-forming ability was evaluated by a method called crystal violet staining, which helps visualize the fungal biomass sticking onto polystyrene plates, and through scanning electron microscopy for detailed inspection.
  • The researchers determined the minimum inhibitory concentrations (MICs) of four antifungal drugs (amphotericin B, fluconazole, itraconazole, and caspofungin) that are required to inhibit the growth of the strains in a free-floating (planktonic) state.
  • Then, they evaluated the susceptibility of fully formed biofilms to these antifungal drugs by checking their metabolic activity after exposure to the drugs. This was done using the XTT oxidoreduction indicator.
  • Data collected were subjected to statistical analysis through ANOVA and Tukey’s post-test. P-values less than 5% were considered to have a significant result.

Key Findings of the Research

  • From the 15 strains tested, eight were capable of producing biofilms. They were categorized into strong (1 strain), moderate (3 strains), and weak (4 strains) producers based on the amount of crystal violet retained by the fungal biomass.
  • The metabolic activity of one C. tropicalis biofilm was found not to decrease even after exposure to the tested antifungal drugs, implying that it is resistant to these medications.
  • Of the eight biofilm-producing strains, the metabolic activities of five were reduced when exposed to amphotericin B, but not to the other drugs.
  • Significant reduction in metabolic activity after exposure to fluconazole, itraconazole, and caspofungin, but not to amphotericin B, was found in one strain of C. parapsilosis sensu stricto and one C. glabrata.

Conclusions Drawn from the Research

  • The findings of the study illustrate that Candida from horses’ ocular conjunctiva can form biofilms.
  • As biofilms generally make the fungi more resilient to treatment, the results suggest these biofilms can contribute to complications in the treatment of horses’ fungal keratitis (a fungal infection of the eye).

Cite This Article

APA
Brilhante RSN, Bittencourt PV, de Souza Collares Castelo-Branco D, de Melo Guedes GM, de Oliveira JS, Alencar LP, de Aguiar Cordeiro R, Pinheiro M, Nogueira-Filho EF, de Aquino Pereira-Neto W, Sidrim JJC, Rocha MFG. (2017). Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis? Vet Ophthalmol, 20(6), 539-546. https://doi.org/10.1111/vop.12465

Publication

ISSN: 1463-5224
NlmUniqueID: 100887377
Country: England
Language: English
Volume: 20
Issue: 6
Pages: 539-546

Researcher Affiliations

Brilhante, Raimunda Sâmia Nogueira
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Bittencourt, Paula Vago
  • Postgraduate Program in Veterinary Sciences, School of Veterinary Medicine, State University of Ceará, Fortaleza, CE, Brazil.
de Souza Collares Castelo-Branco, Débora
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
de Melo Guedes, Glaucia Morgana
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
de Oliveira, Jonathas Sales
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Alencar, Lucas Pereira
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
de Aguiar Cordeiro, Rossana
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Pinheiro, Mariana
  • Postgraduate Program in Veterinary Sciences, School of Veterinary Medicine, State University of Ceará, Fortaleza, CE, Brazil.
Nogueira-Filho, Evilázio Fernandes
  • Postgraduate Program in Veterinary Sciences, School of Veterinary Medicine, State University of Ceará, Fortaleza, CE, Brazil.
de Aquino Pereira-Neto, Waldemiro
  • Department of Transport Engineering, Federal University of Ceará, Fortaleza, CE, Brazil.
Sidrim, José Júlio Costa
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
Rocha, Marcos Fábio Gadelha
  • Department of Pathology and Legal Medicine, Graduate Program in Medical Microbiology, Specialized Medical Mycology Center, School of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil.
  • Postgraduate Program in Veterinary Sciences, School of Veterinary Medicine, State University of Ceará, Fortaleza, CE, Brazil.

MeSH Terms

  • Amphotericin B / pharmacology
  • Animals
  • Antifungal Agents / pharmacology
  • Azoles / pharmacology
  • Biofilms / drug effects
  • Candida / classification
  • Candida / drug effects
  • Candida / physiology
  • Candida / ultrastructure
  • Caspofungin
  • Conjunctiva / microbiology
  • Echinocandins / pharmacology
  • Eye Infections, Fungal / microbiology
  • Eye Infections, Fungal / veterinary
  • Fluconazole / pharmacology
  • Horse Diseases / microbiology
  • Horses
  • Itraconazole / pharmacology
  • Keratitis / microbiology
  • Keratitis / veterinary
  • Lipopeptides / pharmacology
  • Microbial Sensitivity Tests

Citations

This article has been cited 4 times.
  1. Mohammadi F, Charkhchian M, Mirzadeh M. Phenotypic and genotypic characterization of virulence markers and antifungal susceptibility of oral Candida species from diabetic and non-diabetic hemodialysis patients.. BMC Oral Health 2023 May 4;23(1):261.
    doi: 10.1186/s12903-023-02970-8pubmed: 37143002google scholar: lookup
  2. Fiallos NM, Ribeiro Aguiar AL, da Silva BN, Pergentino MLM, Rocha MFG, Sidrim JJC, Maia DCBSC, Cordeiro RA. The Potential of Phenothiazines against Endodontic Pathogens: A Focus on Enterococcus-Candida Dual-Species Biofilm.. Antibiotics (Basel) 2022 Nov 5;11(11).
    doi: 10.3390/antibiotics11111562pubmed: 36358217google scholar: lookup
  3. Mohammadi F, Ghasemi Z, Familsatarian B, Salehi E, Sharifynia S, Barikani A, Mirzadeh M, Hosseini MA. Relationship between antifungal susceptibility profile and virulence factors in Candida albicans isolated from nail specimens.. Rev Soc Bras Med Trop 2020;53:e20190214.
    doi: 10.1590/0037-8682-0214-2019pubmed: 32049200google scholar: lookup
  4. El-Houssaini HH, Elnabawy OM, Nasser HA, Elkhatib WF. Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients.. BMC Infect Dis 2019 Jan 16;19(1):54.
    doi: 10.1186/s12879-019-3685-0pubmed: 30651066google scholar: lookup